Wenqing Ma

ORCID: 0000-0002-7475-5655
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA modifications and cancer
  • Ovarian cancer diagnosis and treatment
  • Cancer-related molecular mechanisms research
  • Marine Sponges and Natural Products
  • Angiogenesis and VEGF in Cancer
  • Protease and Inhibitor Mechanisms
  • Mangiferin and Mango Extracts
  • Lung Cancer Treatments and Mutations
  • PI3K/AKT/mTOR signaling in cancer
  • Cancer therapeutics and mechanisms
  • Neuroendocrine Tumor Research Advances
  • Circular RNAs in diseases
  • Synthesis and Biological Activity

Harbin Medical University
2019-2022

Heilongjiang Academy of Sciences
2020-2022

82th Hospital of Pla
2008

Epithelial carcinoma is a subtype of ovarian cancers, with the highest lethality among all cancer subtypes. Hitherto surgical excision combined chemotherapy has been most extensively employed method in clinical treatment. However, disease relapses very frequently, calling for more effective therapies. Mangiferin, natural xanthone glucoside, displayed promising anti-cancer activities by vitro studies, but its therapeutic value epithelial treatment, either vivo or remained to be known. This...

10.1016/j.phymed.2020.153267 article EN cc-by-nc-nd Phytomedicine 2020-06-15

Ovarian Clear Cell Carcinoma (OCCC) displays distinctive clinical and molecular characteristics confers the worst prognosis among all ovarian carcinoma histotypes when diagnosed at advanced stage because of lack effective therapy. IGF2BP3 is an RNA binding protein that modulates gene expression by posttranscriptional action. In this study, we investigated roles in progression OCCC. We used 328 OCCCs from AOVT (the Alberta Tumor Type study) COEUR Canadian Experimental Unified Resource)...

10.3389/fonc.2019.01570 article EN cc-by Frontiers in Oncology 2020-01-29

Ovarian Clear Cell Carcinoma (OCCC) displays distinctive clinical and molecular characteristics confers the worst prognosis among all ovarian carcinoma histotypes when diagnosed at advanced stage because of lack effective therapy. IGF2BP3 is an RNA binding protein that modulates gene expression by posttranscriptional action. In this study, we investigated roles in progression OCCC. We used 328 OCCCs from AOVT (the Alberta Tumor Type study) COEUR Canadian Experimental Unified Resource)...

10.2139/ssrn.3386275 article EN SSRN Electronic Journal 2019-01-01
Coming Soon ...